10 March 2021Seeking new biomarkers with diffuse correlation spectroscopy and next generation devices for transcranial assessment of cerebral hemodynamics
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
I will first show the latest advances in testing diffuse correlation spectroscopy (DCS) in neuro-monitoring applications and how new biomarkers of cerebral health are emerging through improved technology. This will be illustrated through clinical examples from several studies in clinics. Then I will describe next generation devices which are pushing the technology towards in both the direction of regulatory approvals and also in low-cost, wearable implementations.
Turgut Durduran
"Seeking new biomarkers with diffuse correlation spectroscopy and next generation devices for transcranial assessment of cerebral hemodynamics", Proc. SPIE 11629, Optical Techniques in Neurosurgery, Neurophotonics, and Optogenetics, 1162905 (10 March 2021); https://doi.org/10.1117/12.2595078
The alert did not successfully save. Please try again later.
Turgut Durduran, "Seeking new biomarkers with diffuse correlation spectroscopy and next generation devices for transcranial assessment of cerebral hemodynamics," Proc. SPIE 11629, Optical Techniques in Neurosurgery, Neurophotonics, and Optogenetics, 1162905 (10 March 2021); https://doi.org/10.1117/12.2595078